최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국산학기술학회논문지 = Journal of the Korea Academia-Industrial cooperation Society, v.21 no.4, 2020년, pp.226 - 235
This study was undertaken to investigate factors that affect the assessment of complications in diabetic eye and kidney diseases. Data was obtained from the National Community Health Survey, 2017. The subjects included were 25,829 respondents who had been diagnosed with diabetes. Logistic regression...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
당뇨병성 망막병증은 무엇인가? | 특히 당뇨병성 망막병증은 당뇨병의 가장 흔한 미세혈관 합병증이며[12], 당뇨병성 망막병증은 모세혈관 변화로 실명의 원인이 될 수 있다[13]. 2010년 세계적 당뇨병성 망막병증 유병율은 34. | |
당뇨성 합병증 검사 수검율을 높이기 위해 무엇을 해야 하는가? | 결론적으로 당뇨성 합병증 검사 수검율을 높이기 위해서는 당뇨병 환자를 대상으로 당뇨성 합병증 검사의 종류와 검사 시기가 포함된 당뇨병 관리 교육체계와 당화혈색소 및 혈당수치를 인지시킬 수 있는 다양한 홍보 방법 등이 개발되어야 할 것으로 생각된다. 그리고 당뇨병 관리를 위한 가이드라인 개발하고, 국가차원에서 국가검진제도에 당뇨성 합병증 검사 선별검사항목을 포함하는 등 시스템이 필요할 것으로 보인다. | |
성공적인 당뇨병 관리를 위해 무엇을 해야 하는가? | 성공적인 당뇨병 관리는 신체활동과 같은 건강한 생활 양식의 변화, 약물복용 및 관리, 혈당 자기모니터링 같은 질병 자가 관리, 눈과 신장 합병증 선별검사 같은 당뇨병 합병증 예방관리가 중요하다[9]. 하지만, 조절되지 않는 당뇨병은 관상동맥질환, 뇌졸중, 말초혈관질환 같은 대혈 관 합병증과 당뇨병성신증으로 인한 만성신부전, 당뇨성 망막병증, 당뇨성신경병증 같은 미세혈관 합병증을 초래 한다[11]. |
S. Y. Kim, E. H. Nah, S. Cho. "Prevalence of Comorbidities among Patients with Diabetes", J Health Info Stat, Vol.43, No.3, pp.237-244, August 2018. DOI: https://doi.org/10.21032/jhis.2018.43.3.237
World Health Organization. "Diabetes [Internet]". World Health Organization. WHO 2020. [cited 28 February 2018]. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes
Statistics Korea, "Diabetic prevalence trend: sex, over 30 years old" [Internet]. Seoul. Statistics Korea 2019. [cited 2019 July 20]. Available from http://kosis.kr/statHtml/statHtml.do?orgId117&tblIdDT_11702_N102
Health Insurance Review and Assessment Service/National Health Insurance Service, "2017 National Health Insurance statistical yearbook", [Internet]. Gangwon-do. Health Insurance Review and Assessment Service/National Health Insurance Service. 2018. [cited 2019 July 05], Available from: https://www.hira.or.kr/bbsDummy.do?pgmidHIRAA020045020000&brdScnBltNo4&brdBltNo2310&pageIndex1#none
K. N. D. Van Eijk, J. W. Blom, J. Gussekloo, B. C. P. Polak, Y. Groeneveld. "Diabetic retinopathy screening in patients with diabetes mellitus in primary care: Incentives and barriers to screening attendance", Diabetes research and clinical practice, Vol.96, No.1, pp.10-16, 2012. DOI: https://doi.org/10.1016/j.diabres.2011.11.003
Y. L. Hsieh, F. H.Lee, C. L. Chen, M. F. Chang, P. H. Han. "Factors influencing intention to receive examination of diabetes complications", Asian Nursing Research, Vol.10, No.4, pp.289-294, 2016. DOI: https://doi.org/10.1016/j.anr.2016.10.004
Statistics Korea. "Annual Diabetes eye and Renal Disease Complication Test Rate(over 30 years old)", [Internet]. Seoul. Ministry of Health and Welfare/Korea Center for Disease control & Prevention. 2019. [cited 2019 July 20]. Available from: http://kosis.kr/statisticsList/statisticsListIndex.do?menuIdM_01_01&vwcdMT_ZTITLE&parmTabIdM_01_01&statId2008057&themaIdD#117_A01.3
American Diabetes Association. "Strategies for Improving Care. Diabetes Care", Vol. 38, No.1, pp.S5-S7, 2015. DOI: https://doi.org/10.2337/dc15-S004
American Diabetics Disease. "Complications", [Internet]. Arlington. American Diabetes Association. 2019. [cited 2019 July 20]. Available from: http://www.diabetes.org/living-with-diabetes/complications/
J. L. Harding, M. E. Pavkov, D. Magliano, J. E. Shaw, E. W. Gregg. "Global trends in diabetes complications: a review of current evidence", Diabetologia, Vol.62, No.1, pp.3-16, 2019. DOI: https://doi.org/10.1007/s00125-018-4711-2
E. Prokofyeva, E. Zrenner. "Epidemiology of major eye diseases leading to blindness in Europe: a literature review", Ophthalmic Res, Vol.47, No.4, pp.171-188, 2012. DOI: https://doi.org/10.1159/000329603
M. N. Martin, W. U. Michael. "Diabetic retinopathy-ocular complications of diabetes mellitus", World journal of Diabetes, Vol.6, No.3, pp489-499, 2015. DOI: http://dx.doi.org/10.4239/wjd.v6.i3.489
J. W. Yau,. L. Rogers, R. Kawasaki, E. L. Lamoureux, J. W. Kowalski, T. Bek. et al. "Global prevalence and major risk factors of diabetic retinopathy", Diabetes Care, Vol.35, No.3, pp.556-564, 2015. DOI: https://doi.org/10.2337/dc11-1909
I. Kocur, S. Resnikoff. "Visual impairment and blindness in Europe and their prevention", British Journal of Ophthalmology, Vol.86, pp.716-722. 2002. DOI: http://dx.doi.org/10.1136/bjo.86.7.716
E. Meda. Pavkov, L. Jessica. Harding, B. Chiu-Fang Chou, Jinan. Saaddine. "Prevalence of Diabetic Retinopathy and Associated Mortality Among Diabetic Adults With and Without Chronic Kidney Disease", American Journal of Ophthalmology, Vol.198, pp.200-208, 2019. DOI: https://doi.org/10.1016/j.ajo.2018.10.019
W. C. Lee, N. Y. Hong, J. B. Park, B. Y. Bae. "Improving Eye Examination Rate in Diabetic Patients in Bucheon", Monthly Community Health Report, pp.20-21. May 2018. DOI: https://chs.cdc.go.kr/chs/hd/hdMain.do
P. Rossing, M. Marie Frimodt-Moller. "Clinical Features and Natural Course of Diabetic Nephropathy", Diabetic Nephropathy, pp.21-32, 2019.
O. I. Ameh, I. G. Okpechi, C. Agyemang, A. P. Kengne. "Global, Regional, and Ethnic Differences in Diabetic Nephropathy", Diabetic Nephropathy, pp.33-44, 2019.
A. M. Warren, S. T. Knudsen, M. E. Cooper. "Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies", Journal Expert Opinion on Therapeutic Targets, Vol.23, No.7, pp.579-591, 2019. DOI: https://doi.org/10.1080/14728222.2019.1624721
Y. E. Son, S. Y. Ryu, J. Park, M. A. Han, H. M. Gu. "The Associated Factors with Utilization of Tests for Diabetes Complication and Hemoglobin A1c among Some Diabetes Patients", Health Policy and Management, Vol.26, No.3, pp.207-218, 2016. DOI: http://dx.doi.org/10.4332/KJHPA.2016.26.2.207
Health Insurance Review & Assessment Service. "Guidelines for Changes in the Standards for Diabetes Adequacy Assessment", [Internet]. Seoul. Health Insurance Review & Assessment Service. 2019. [cited 2019 July 05]. Available from : http://www.hira.or.kr/bbsDummy.do?pgmidHIRAA020002000100&brdScnBltNo4&brdBltNo7324
S. H. Lee, H. L. Kim. "Comparision of Health Behaviors, Diabetes Mellitus(DM) Management and Health-related Quality of Life(HRQoL) between DM Groups with and without Diabetic Education Experience", Journal of agricultural medicine and community health, Vol.43, No.2, pp.:85-96, 2018. DOI: https://doi.org/10.5393/JAMCH.2018.43.2.085
S. J. Park, H. J. Seo, D. Y. Lee, D. H. Nam. "Main Reasons for and Associated Factors of the First Fundus Examination in Diabetic Patients", J Korean Ophthalmol Soc, Vol.57, No.7, pp.1080-1086, 2016. DOI: http://dx.doi.org/10.3341/jkos.2016.57.7.1080
E. Dervan, D. Lillis, L. Flynn, A. Staines, D. O'Shea. "Factors that influence the patient uptake of diabetic retinopathy screening", Irish Journal of Medical Science, Vol.177, No.4, pp.303-308, 2018.
A. M. Kriska, M. A. Pereira, R. L. Hanson, M. P. De Courten, P. Z. Zimmet, K. G. M. Alberti. et al. "Association of physical activity and serum insulin concentrations in two populations at high risk for type 2 diabetes but differing by BMI", Diabetes care, Vol.24, No7, pp.1175-1180, 2001. DOI: https://doi.org/10.2337/diacare.24.7.1175
American Diabetes Association. "Strategies for Improving Care", Diabetes Care, Vol.38, No.1, pp. S5-S7, January 2015. DOI: https://doi.org/10.2337/dc15-S004
H. T. Lim, K. S. Cho. "Factors associated with screening for diabetic retinopathy in diabetic patients aged ${\geq}$ 40 years using the KNHANES IV", J Korean Ophthalmol Soc, Vol.53, No.4, pp.516-521, 2012. DOI: http://dx.doi.org/10.3341/jkos.2012.53.4.516
S. Y. Lee, C. W. Kim, J. H. Kang, N. K. Seo. "Unmet healthcare needs depending on employment status", Health Policy, Vol.119, pp.899-906, 2015. DOI: http://dx.doi.org/10.1016/j.healthpol.2014.09.007
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.